GRAL – grail, inc. (US:NASDAQ)

News

GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BeOne Medicines (ONC) Reports $1.5B Revenue for Q4, $1.1B from Lymphoma Treatment [Yahoo! Finance]
GRAIL to Present at the TD Cowen 46th Annual Health Care Conference
GRAIL (NASDAQ:GRAL) was given a new $60.00 price target on by analysts at Morgan Stanley.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com